Muscle function in juvenile chronic arthritis

H Lindehammar1, E Bäckman

  • 1Department of Pediatrics, Faculty of Health Sciences, University Hospital, Linköping, Sweden.

Insights

Children with juvenile chronic arthritis (JCA) experience reduced muscle strength and thickness. This impairment is most severe in muscles located near inflamed joints, impacting overall muscle function.

Area of Science:

  • Pediatric Rheumatology
  • Musculoskeletal Health
  • Arthritis Research

Background:

  • Juvenile chronic arthritis (JCA) is a condition affecting children, potentially impacting musculoskeletal development and function.
  • Understanding the specific effects of JCA on muscle strength and thickness is crucial for effective management and rehabilitation.

Purpose of the Study:

  • To investigate and quantify the impact of juvenile chronic arthritis (JCA) on muscle strength and thickness in affected children.
  • To compare muscle function in children with JCA to healthy controls and assess the influence of joint inflammation proximity.

Main Methods:

  • Evaluated voluntary isometric, isokinetic, and nonvoluntary isometric muscle strength in 20 children with JCA.
  • Measured quadriceps muscle thickness using ultrasound and compared results with reference values from healthy children and a matched control group.

Main Results:

  • Children with JCA exhibited reduced isometric muscle strength in knee extensors, elbow flexors, and wrist dorsiflexors.
  • Muscle strength deficits were more pronounced (45-65% of expected) near inflamed joints compared to muscles without adjacent arthritis (80-90% of expected).
  • Quadriceps muscle thickness was reduced in children with JCA, regardless of knee joint involvement.

Conclusions:

  • Children diagnosed with JCA demonstrate significant reductions in both muscle strength and thickness.
  • The degree of muscle impairment in JCA is closely correlated with the proximity of muscles to inflamed joints.
Abstract

Related Concept Videos

Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...